In this article (a study in collaboration with the University of Zurich and Hospital Dr. Peset, Hospital La Fe and Hospital de Manises, in Valencia) we demonstrate that the succinate receptor SUCNR1 is increased in Crohn’s patients with fistulas, and that this receptor mediates a process involved in the development of fistulas called epithelial-mesenchymal transition. Our results endorse SUCNR1 as a new pharmacological target for the treatment of complications associated with Crohn’s patients.
Article in Cells
- CONFERENCE: ADVANCES IN COMPLICATED IN IBD. 17 February 2023, in Fundación-ADEIT
- Research stay in Dublin
- Our article published recently in the British Journal of Pharmacology
- Congratulations to our colleague Dolo Ortiz, who has recently been named Senior Lecturer of the University of Valencia
- Congratulations to Sara Calatayud, member of our research group, who has recently become Full Professor of Pharmacology.
abacavir acif antiretrovirals autophagy cerebral-vascular damage cGKI chronic liver disease ciberehd colon Crohn's disease designations doctoral prize doctoral studies efavirenz excellence research group fibroblast fibrosis fibrostat fpi fpu gut hiv hospital de manises hospital universitario dr. peset hospital universitario y politécnico la fe incorporations inflammatory bowel disease liver liver injury macrophages master degree mitophagy newspapers and journals p2x7 pharmacology prometeo programme psoriasis rilpivirina sucnr1 technician thrombosis tytgat institute for liver and intestinal research university of zurich vascular reactivity vitamin d